James Wilson turns to old mentor for gene therapy startup's star-studded $115M launch round
Gene therapies have long held promise for rare diseases — many of which are monogenic — as an elegant cure that corrects the singular underlying genetic defects …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
